Endovascular Arch Repair: Endograft Design Options and Worldwide Results
B-/F-TEVAR has emerged as a feasible treatment option for selected high-risk patients with aortic arch pathology, achieving high technical success. Although outcomes may improve with growing experience, stroke remains a significant complication, and reintervention rates highlight the need for long-term durability.
Authors
- Maximilian Kreibich (ORCID: https://orcid.org/0000-0003-3099-7254)
- Mario Lescan (ORCID: https://orcid.org/0000-0002-3124-4994)
- Philipp Discher
- Ingrid Schusterová (ORCID: https://orcid.org/0000-0002-0410-6967)
- Joseph Kletzer (ORCID: https://orcid.org/0000-0002-1644-1754)
- Aleksandar Dimov
- Martin Czerny (ORCID: https://orcid.org/0000-0003-4766-9775)
- Stoyan Kondov (ORCID: https://orcid.org/0000-0002-1892-1487)
- Roman Gottardi (ORCID: https://orcid.org/0000-0001-9716-3655)
- Tim Berger (ORCID: https://orcid.org/0000-0001-6263-9123)
Institutions
- University of Freiburg (DE)
- Slovak Academy of Sciences (SK)
- University Medical Center Freiburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Universitäts-Herzzentrum Freiburg-Bad Krozingen (DE)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1093/ejcts/ezaf273
- Primary Topic
- Aortic aneurysm repair treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00